SPBC354.07c Antibody

What is SPBC354.07c and why is it relevant for fission yeast research?

SPBC354.07c is a specific gene locus in Schizosaccharomyces pombe (fission yeast). It belongs to the same genomic region as SPBC354.03 (swd3), which encodes a WD repeat protein involved in chromatin modification processes . Antibodies against proteins encoded by this genomic region are valuable tools for investigating protein function, localization, and interactions in fission yeast. Understanding the role of proteins in this genomic region provides insights into fundamental cellular processes in this important model organism.

What are the standard protocols for using antibodies in fission yeast research?

Standard antibody usage in fission yeast research typically involves western blotting, immunoprecipitation, and immunofluorescence microscopy. For western blotting, cell extracts from exponentially growing cells are collected, proteins are separated on SDS-polyacrylamide gels and blotted onto PVDF membranes. The membranes are then probed with the specific antibody of interest . For immunoprecipitation, cells are collected and resuspended in lysis buffer with protease inhibitors before lysis by bead beating. The lysates are then incubated with appropriate beads (such as IgG sepharose for TAP-tagged proteins) at 4°C for 2-3 hours, followed by washing and elution in SDS loading buffer . These standard protocols can be adapted for SPBC354.07c antibody applications based on specific experimental requirements.

How should I prepare fission yeast samples for optimal antibody performance?

For optimal antibody performance with fission yeast samples, proper cell lysis and protein extraction are critical. Cells should be harvested during exponential growth phase unless investigating specific conditions (like starvation or stress response). Standard cell lysis involves resuspending cells in lysis buffer containing protease inhibitors followed by mechanical disruption using glass beads . For certain applications, especially when studying proteins that might undergo rapid degradation or modification, it's advisable to include phosphatase inhibitors and perform all procedures at 4°C. The extraction method should be optimized based on the cellular localization and properties of the SPBC354.07c-encoded protein to ensure maximum recovery and preservation of native structure.

What controls should I include when using SPBC354.07c antibody?

When using SPBC354.07c antibody, essential controls include: (1) A negative control using samples from deletion mutants lacking the target gene when available, (2) Loading controls such as actin antibody to normalize protein levels across samples (as demonstrated in Upf1:TAP protein detection experiments where actin was used as a control) , (3) For tagged protein detection, appropriate tag-only controls should be included, and (4) For immunoprecipitation experiments, non-specific IgG controls should be performed to identify background binding. These controls ensure experimental rigor and help validate the specificity of antibody-based detection.

How can I optimize co-immunoprecipitation experiments using SPBC354.07c antibody?

Optimizing co-immunoprecipitation with SPBC354.07c antibody requires careful consideration of lysis conditions and binding parameters. Based on established protocols for fission yeast, cells should be collected and resuspended in lysis buffer with protease inhibitors prior to lysis by bead beating . The choice of lysis buffer is critical—for protein-protein interactions that may be sensitive to ionic strength, test buffers with varying salt concentrations (typically 100-500 mM NaCl). For interactions that might be mediated by RNA, consider including RNase treatment in control samples. Optimize incubation time with the antibody-conjugated beads (typically 2-3 hours at 4°C as used in similar studies) . After washing with lysis buffer three times, elute proteins in SDS loading buffer and analyze by Western blotting using appropriate antibodies against suspected interaction partners.

What approaches can resolve non-specific binding issues with SPBC354.07c antibody?

Non-specific binding is a common challenge with antibodies in yeast research. To resolve this issue with SPBC354.07c antibody, implement a multi-faceted approach: (1) Increase blocking stringency using 5% BSA or milk in TBST, (2) Perform pre-clearing steps by incubating cell lysates with beads alone before adding antibody, (3) Include competitive blocking agents—for TAP-tag antibodies, consider including non-tagged cell extract in blocking solutions , (4) Optimize salt concentration in wash buffers (start with standard conditions and increase incrementally to 300-500 mM NaCl), (5) Add mild detergents (0.1-0.5% Triton X-100 or NP-40) to reduce hydrophobic non-specific interactions, and (6) Consider using a different antibody format (monoclonal vs. polyclonal) depending on the nature of non-specific binding observed.

How can I validate SPBC354.07c antibody specificity in fission yeast?

Rigorous validation of SPBC354.07c antibody specificity is essential for reliable research outcomes. A comprehensive validation approach includes: (1) Western blot analysis comparing wild-type strains with deletion mutants lacking the target gene, (2) If using epitope-tagged versions, compare detection signals between tagged and untagged strains, (3) Peptide competition assays where the antibody is pre-incubated with purified target peptide before use, (4) Analysis of signal in cells where the target is overexpressed versus normal expression, and (5) Cross-validation using orthogonal methods such as mass spectrometry to confirm the identity of immunoprecipitated proteins. For immunofluorescence applications, comparing the localization pattern with GFP-tagged versions of the protein provides additional validation.

What methodological approaches enable detection of post-translational modifications using SPBC354.07c antibody?

Detecting post-translational modifications (PTMs) of proteins encoded by SPBC354.07c requires specialized approaches. For phosphorylation analysis: (1) Use phospho-specific antibodies if available, or (2) Perform immunoprecipitation with SPBC354.07c antibody followed by western blotting with generic phospho-serine/threonine/tyrosine antibodies. For more comprehensive PTM detection: (3) Immunoprecipitate the protein using SPBC354.07c antibody and analyze by mass spectrometry, (4) Use mobility shift assays by comparing migration patterns in SDS-PAGE before and after treatment with specific phosphatases or other enzymes that remove PTMs, and (5) For ubiquitination studies, consider performing immunoprecipitation under denaturing conditions to disrupt protein-protein interactions while preserving covalent modifications. Include specific inhibitors of PTM-removing enzymes in lysis buffers to preserve the modifications during sample preparation.

How can SPBC354.07c antibody be applied in chromatin immunoprecipitation (ChIP) experiments?

For ChIP applications with SPBC354.07c antibody, follow an optimized protocol based on established fission yeast procedures: (1) Cross-link cells with 1% formaldehyde for 15-30 minutes, (2) Prepare chromatin through cell lysis and sonication to achieve DNA fragments of 200-500 bp, (3) Immunoprecipitate using SPBC354.07c antibody pre-bound to protein A/G beads, with appropriate controls including IgG and input samples, (4) Wash extensively to remove non-specific binding, (5) Reverse cross-links and purify DNA using PCR cleanup columns as described in published protocols , and (6) Analyze by PCR using primers specific to regions of interest or by next-generation sequencing for genome-wide binding profile. This approach can reveal genomic binding sites of the protein encoded by SPBC354.07c, providing insights into its role in transcriptional regulation or chromatin organization.

What protocols enable combined immunofluorescence and live-cell imaging with SPBC354.07c antibody?

Combining immunofluorescence with live-cell imaging requires careful experimental design. For fixed-cell immunofluorescence: (1) Fix cells according to standard protocols, typically with 3.7% formaldehyde for 30 minutes, (2) Permeabilize cell walls with zymolyase treatment followed by membrane permeabilization with detergent, (3) Block and incubate with SPBC354.07c antibody followed by fluorescently-labeled secondary antibody, and (4) Image using standard fluorescence microscopy techniques as described in established fission yeast protocols . For correlative live-cell and immunofluorescence imaging: (5) First perform live-cell imaging with cells expressing fluorescent proteins or dyes compatible with subsequent fixation, (6) Record cell positions, (7) Fix and process for immunofluorescence with SPBC354.07c antibody, and (8) Return to the same positions to image the immunolabeled structures. This approach allows correlation between dynamic behaviors observed in live cells and specific protein localization.

How can I apply SPBC354.07c antibody in studies of protein dynamics during cellular stress responses?

Investigating protein dynamics during stress responses with SPBC354.07c antibody requires careful experimental design: (1) Establish appropriate stress conditions (oxidative stress, nutrient limitation, temperature shifts) based on published protocols for fission yeast , (2) Collect samples at multiple time points after stress induction, (3) Perform western blot analysis with SPBC354.07c antibody to track changes in protein levels, (4) For localization changes, use immunofluorescence at the same time points, (5) Consider combining with immunoprecipitation to identify stress-specific protein interaction partners, and (6) For quantitative analysis, implement replicate experiments with appropriate normalization controls. This approach can reveal how the protein encoded by SPBC354.07c responds to specific cellular stresses, potentially identifying novel functions in stress adaptation or signaling pathways.

What approaches enable quantitative analysis of protein-protein interactions using SPBC354.07c antibody?

For quantitative analysis of protein-protein interactions using SPBC354.07c antibody, implement these advanced methodological approaches: (1) Quantitative co-immunoprecipitation followed by western blotting with appropriate loading controls and standard curves of purified proteins, (2) Proximity ligation assays (PLA) for in situ detection and quantification of interactions in fixed cells, (3) For more sensitive detection, consider tandem affinity purification approaches using SPBC354.07c-TAP tagged strains followed by mass spectrometry for identification and quantification of interaction partners , (4) Implement SILAC (Stable Isotope Labeling with Amino acids in Cell culture) or TMT (Tandem Mass Tag) labeling for comparative quantitative proteomics of immunoprecipitated complexes under different conditions, and (5) For transient or weak interactions, consider crosslinking prior to immunoprecipitation. These approaches provide quantitative information about interaction stoichiometry and dynamics under different cellular conditions.

How can SPBC354.07c antibody be integrated with genetic screening approaches?

Integrating SPBC354.07c antibody with genetic screening involves several strategic approaches: (1) Perform immunoprecipitation with SPBC354.07c antibody in a library of fission yeast mutants to identify genetic backgrounds that alter interaction partners or post-translational modifications, (2) Use synthetic genetic array (SGA) methodology to identify genetic interactions, then analyze protein expression/localization using the antibody in strains carrying relevant mutations, (3) For phenotypic screens where SPBC354.07c may be involved, use the antibody to assess protein levels and localization in mutants displaying phenotypes of interest, and (4) In genome-wide screens for protein localization changes, use high-throughput immunofluorescence with SPBC354.07c antibody. This integrated approach connects genetic perturbations with biochemical and cellular phenotypes, providing mechanistic insights into gene function.

What methodologies enable detection of RNA-protein interactions involving SPBC354.07c-encoded proteins?

For studying RNA-protein interactions involving SPBC354.07c-encoded proteins, adapt RNA immunoprecipitation (RIP) protocols: (1) Crosslink cells using UV or formaldehyde to preserve RNA-protein interactions, (2) Lyse cells under conditions that preserve RNA integrity, including RNase inhibitors, (3) Immunoprecipitate using SPBC354.07c antibody following established protocols similar to those used for Upf1:TAP protein , (4) Extract and purify associated RNAs, (5) Analyze bound RNAs using RT-PCR for specific targets or RNA sequencing for genome-wide identification, and (6) Validate interactions using orthogonal methods such as in vitro binding assays or reporter systems. This approach can identify RNA targets of the protein encoded by SPBC354.07c, providing insights into its potential roles in RNA metabolism, processing, or regulation.

How should mass spectrometry analysis be optimized when using immunoprecipitation with SPBC354.07c antibody?

Optimizing mass spectrometry analysis with SPBC354.07c immunoprecipitation requires careful consideration of sample preparation and analysis parameters: (1) Perform immunoprecipitation under conditions that preserve protein-protein interactions of interest, similar to established protocols for fission yeast proteins , (2) Consider using DSSO or other MS-cleavable crosslinkers to capture transient interactions, (3) Implement a staged elution strategy—first with gentle buffers to preserve complexes, then with more stringent conditions to ensure complete elution of the bait protein, (4) Process samples with minimal keratin contamination in a clean environment, (5) For identification of post-translational modifications, use enrichment strategies specific to the modification of interest prior to MS analysis, (6) Analyze data using appropriate search parameters that account for expected modifications and proper statistical filtering to minimize false discoveries, and (7) Always include appropriate negative controls (IgG immunoprecipitation, immunoprecipitation from cells lacking the target) for background subtraction.

How can SPBC354.07c antibody be applied to study protein behavior during cellular quiescence?

To study protein behavior during cellular quiescence using SPBC354.07c antibody: (1) Induce quiescence in fission yeast cultures using established nitrogen starvation protocols similar to those described for cytoplasmic freezing studies , (2) Collect samples at defined timepoints during entry into, maintenance of, and exit from quiescence, (3) Perform western blot analysis with SPBC354.07c antibody to track protein level changes, (4) Use immunofluorescence to monitor potential relocalization during quiescence, (5) Combine with co-immunoprecipitation to identify quiescence-specific interaction partners, (6) Consider proteomic approaches to identify quiescence-specific post-translational modifications, and (7) Compare results with known quiescence-regulated genes to contextualize findings. This methodological approach can reveal how the SPBC354.07c-encoded protein functions during this specialized cellular state, potentially identifying novel roles in quiescence entry, maintenance, or exit.

What methods enable study of SPBC354.07c-encoded protein interactions with cytoskeletal elements?

To study interactions between SPBC354.07c-encoded proteins and cytoskeletal elements: (1) Perform co-immunoprecipitation with SPBC354.07c antibody followed by western blotting or mass spectrometry to identify cytoskeletal proteins in the immunoprecipitated complex, (2) Use co-localization studies with immunofluorescence against SPBC354.07c and labeled cytoskeletal elements such as actin (using phalloidin) or microtubules (using tubulin antibodies), (3) Analyze protein distribution in cells treated with cytoskeleton-disrupting drugs such as Latrunculin B (LatB) as described in cytoplasmic freezing studies , (4) Implement proximity ligation assays to detect and quantify in situ interactions between the protein of interest and cytoskeletal components, and (5) Consider in vitro binding assays with purified components to test for direct interactions. These approaches can reveal functional relationships between SPBC354.07c-encoded proteins and the cytoskeleton, potentially identifying roles in cellular architecture or dynamics.

How can I detect SPBC354.07c-encoded protein involvement in stress granules or P-bodies?

To investigate SPBC354.07c-encoded protein involvement in stress granules or P-bodies: (1) Induce stress granule formation using appropriate stressors (heat shock, oxidative stress, glucose deprivation) according to established fission yeast protocols, (2) Perform immunofluorescence using SPBC354.07c antibody alongside markers for stress granules (such as poly(A)-binding protein) or P-bodies (such as Dcp2), (3) Quantify co-localization using appropriate image analysis software, (4) For live-cell imaging, combine with fluorescently-tagged markers for these RNA granules, (5) Use immunoprecipitation with SPBC354.07c antibody followed by analysis of known stress granule or P-body components, and (6) Assess the effect of SPBC354.07c deletion or overexpression on stress granule or P-body formation. This methodological approach can determine whether the protein is a component of these RNA-protein assemblies and what role it might play in their formation or function during stress responses.